Clinical Trial

Rezdiffra Pregnancy and Lactation Registry

Recruiting
View on ClinicalTrials.gov →
Summary
To evaluate pregnancy and clinical outcomes in women with NASH and their infants after exposure to Rezdiffra at any time during pregnancy and/or lactation.
Trial Details
NCT Number NCT07541469
Lead Sponsor Madrigal Pharmaceuticals, Inc.
Conditions MASH - Metabolic Dysfunction-Associated Steatohepatitis
Enrollment 10 participants
Start Date 2026-03-04
Primary Completion 2030-04-08 (estimated)
Study Completion 2030-04-08 (estimated)
Updated on ClinicalTrials.gov 2026-04-21